SciELO - Scientific Electronic Library Online

 
vol.82 número12Adaptación de lentes de contacto en 133 ojos con astigmatismo irregular índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Archivos de la Sociedad Española de Oftalmología

versão impressa ISSN 0365-6691

Resumo

ELIAS-DE-TEJADA, M. et al. Photodynamic therapy in angioid streaks. Arch Soc Esp Oftalmol [online]. 2007, vol.82, n.12, pp.741-746. ISSN 0365-6691.

Objetive: To evaluate the efficacy and safety of photodynamic therapy in choroidal neovascularization associated with angioid streaks. Methods: We performed a retrospective study of eleven eyes (eight patients) with subfoveal, juxtafoveal or extrafoveal neovascularization, which received at least one session of photodynamic therapy. Treatment efficacy was evaluated by visual acuity (VA) testing, color photography and fluorescein angiography. The mean follow-up was 13.2 months. Results: Ten eyes presented subfoveal neovascularization, one eye presented juxtafoveal and another eye extrafoveal neovascularization. VA was unchanged in two patients, increased in one patient, and decreased in eight patients following photodynamic therapy. Nine eyes presented conversion to a fibrotic disciform lesion, whereas leakage persisted in two eyes after one session of photodynamic therapy. Recurrence of choroidal neovascularization appeared in three eyes. Conclusions: Photodynamic therapy in choroidal neovascularization related to angioid streaks does not appear to alter the course of this disease, but it does slow its progression.

Palavras-chave : Angioid streaks; photodynamic therapy; choroidal neovascularization.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons